We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$39.1B
AUM Growth
-$26.3M
Cap. Flow
+$1.59B
Cap. Flow %
4.07%
Top 10 Hldgs %
39.91%
Holding
738
New
84
Increased
295
Reduced
215
Closed
110

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$499M
2
SNPS icon
Synopsys
SNPS
+$411M
3
MSFT icon
Microsoft
MSFT
+$380M
4
NFLX icon
Netflix
NFLX
+$354M
5
CI icon
Cigna
CI
+$177M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$546M
2
WFC icon
Wells Fargo
WFC
+$453M
3
PR
Permian Resources
PR
+$229M
4
ELV icon
Elevance Health
ELV
+$195M
5
NVDA icon
NVIDIA
NVDA
+$97.3M

Sector Composition

Rank Sector Weight
1 Technology 31.72%
2 Healthcare 23.65%
3 Communication Services 11.87%
4 Financials 10.29%
5 Consumer Discretionary 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GIII icon
551
G-III Apparel Group
GIII
$1.48B
$539K ﹤0.01%
19,450
+11,828
+155% +$346K
IDEV icon
552
iShares Core MSCI International Developed Markets ETF
IDEV
$31.2B
$521K ﹤0.01%
6,236
-7,723
-55% -$664K
URBN icon
553
Urban Outfitters
URBN
$6.05B
$511K ﹤0.01%
8,065
-541
-6% -$37.1K
VSS icon
554
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
$507K ﹤0.01%
+3,480
New +$526K
PBR icon
555
Petrobras
PBR
$122B
$499K ﹤0.01%
24,048
– –
AMRZ
556
Amrize Ltd
AMRZ
$27.2B
$492K ﹤0.01%
+8,790
New +$504K
YELP icon
557
Yelp
YELP
$1.4B
$486K ﹤0.01%
19,648
-1,013
-5% -$25.7K
SN icon
558
SharkNinja
SN
$21.1B
$485K ﹤0.01%
4,577
– –
LEVI icon
559
Levi Strauss
LEVI
$9.49B
$457K ﹤0.01%
24,715
+6,012
+32% +$123K
BCS icon
560
Barclays
BCS
$94.7B
$439K ﹤0.01%
20,746
-4,300
-17% -$105K
OUT icon
561
Outfront Media
OUT
$5.64B
$436K ﹤0.01%
16,436
-3,262
-17% -$85K
CFG icon
562
Citizens Financial Group
CFG
$30.4B
$430K ﹤0.01%
7,170
-1,636
-19% -$101K
SBH icon
563
Sally Beauty Holdings
SBH
$1.41B
$422K ﹤0.01%
30,495
+14,285
+88% +$218K
NMIH icon
564
NMI Holdings
NMIH
$3.23B
$410K ﹤0.01%
10,930
-12,668
-54% -$491K
ATKR icon
565
Atkore
ATKR
$2.52B
$404K ﹤0.01%
6,856
-203
-3% -$13.2K
ACMR icon
566
ACM Research
ACMR
$6.04B
$401K ﹤0.01%
10,181
-10,106
-50% -$536K
RDY icon
567
Dr. Reddy's Laboratories
RDY
$9.88B
$394K ﹤0.01%
28,441
-315,792
-92% -$4.4M
ALT icon
568
Altimmune
ALT
$545M
$389K ﹤0.01%
126,389
-46,170
-27% -$196K
ETD icon
569
Ethan Allen Interiors
ETD
$581M
$385K ﹤0.01%
17,313
– –
PEN icon
570
Penumbra
PEN
$12.5B
$378K ﹤0.01%
+1,150
New +$389K
CAH icon
571
Cardinal Health
CAH
$53.6B
$377K ﹤0.01%
1,784
-1,159
-39% -$250K
WOR icon
572
Worthington Enterprises
WOR
$2.76B
$376K ﹤0.01%
7,211
-1,653
-19% -$88.5K
GLOB icon
573
Globant
GLOB
$1.37B
$376K ﹤0.01%
8,148
– –
MAS icon
574
Masco
MAS
$16B
$375K ﹤0.01%
+6,205
New +$420K
CMPR icon
575
Cimpress
CMPR
$2.38B
$374K ﹤0.01%
5,117
– –
21 22
23
24 25

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2026 Portfolio in Review

As of Q1 2026, Grantham, Mayo, Van Otterloo & Co (GMO) held 738 positions worth $39.1B, down 0.07% from $39.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $1.59B of net new capital in Q1 2026, opening 84 new positions and adding to 295 existing holdings. Its largest new stake was Synopsys: 910,133 shares worth $361M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lam Research, an estimated $546M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2026 buy was Synopsys: 910,133 shares worth $361M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Mastercard in Q1 2026, an estimated $499M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2026 reduction was Lam Research, cutting an estimated $546M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Comerica in Q1 2026, selling an estimated $36.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $39.1B portfolio in Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 84 new positions and closed 110 in Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 0.07% quarter-over-quarter to $39.1B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.